48.61
price up icon0.43%   0.21
 
loading
Precedente Chiudi:
$48.40
Aprire:
$47.88
Volume 24 ore:
2.43M
Relative Volume:
1.06
Capitalizzazione di mercato:
$7.62B
Reddito:
$1.17B
Utile/perdita netta:
$150.71M
Rapporto P/E:
51.71
EPS:
0.94
Flusso di cassa netto:
$245.03M
1 W Prestazione:
+3.91%
1M Prestazione:
-3.72%
6M Prestazione:
-36.06%
1 anno Prestazione:
-37.03%
Intervallo 1D:
Value
$47.25
$48.79
Intervallo di 1 settimana:
Value
$47.23
$49.02
Portata 52W:
Value
$46.01
$83.62

Bio Techne Corp Stock (TECH) Company Profile

Name
Nome
Bio Techne Corp
Name
Telefono
(612) 379-8854
Name
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Dipendente
3,100
Name
Cinguettio
@biotechne
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
TECH's Discussions on Twitter

Confronta TECH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TECH
Bio Techne Corp
48.61 7.63B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-30 Iniziato Wells Fargo Overweight
2025-04-09 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 Iniziato Evercore ISI Outperform
2025-02-19 Downgrade Robert W. Baird Outperform → Neutral
2024-05-22 Downgrade Citigroup Buy → Neutral
2024-02-08 Iniziato Scotiabank Sector Outperform
2024-02-02 Downgrade Stifel Buy → Hold
2023-12-07 Iniziato UBS Buy
2023-08-28 Iniziato William Blair Outperform
2023-01-10 Aggiornamento Wells Fargo Underweight → Equal Weight
2022-12-14 Iniziato Deutsche Bank Buy
2022-12-12 Aggiornamento Citigroup Neutral → Buy
2022-12-07 Iniziato RBC Capital Mkts Sector Perform
2022-08-25 Iniziato Credit Suisse Outperform
2022-04-25 Downgrade Wells Fargo Equal Weight → Underweight
2021-09-15 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 Aggiornamento Stephens Equal-Weight → Overweight
2021-02-23 Aggiornamento Stifel Hold → Buy
2021-01-25 Reiterato The Benchmark Company Buy
2020-11-10 Iniziato KeyBanc Capital Markets Sector Weight
2020-09-30 Iniziato Atlantic Equities Overweight
2020-07-15 Downgrade Stephens Overweight → Equal-Weight
2020-05-27 Downgrade Stifel Buy → Hold
2020-05-14 Iniziato The Benchmark Company Buy
2020-01-08 Ripresa Stephens Overweight
2020-01-08 Iniziato Wells Fargo Equal Weight
2020-01-07 Iniziato Citigroup Neutral
2019-11-15 Iniziato Stifel Buy
2019-07-02 Aggiornamento Janney Neutral → Buy
2019-01-14 Aggiornamento Stephens Equal-Weight → Overweight
2018-10-31 Downgrade Craig Hallum Buy → Hold
2018-10-17 Iniziato Goldman Neutral
2018-06-15 Iniziato Argus Buy
2017-07-13 Iniziato Wells Fargo Market Perform
2017-02-09 Iniziato Citigroup Buy
2017-01-18 Iniziato Deutsche Bank Buy
2016-11-10 Ripresa Leerink Partners Outperform
2015-01-21 Reiterato Robert W. Baird Outperform
2013-09-20 Aggiornamento Robert W. Baird Neutral → Outperform
Mostra tutto

Bio Techne Corp Borsa (TECH) Ultime notizie

pulisher
May 31, 2025

Wells Fargo Begins Coverage of Bio-Techne (TECH) Stock, Gives PT of $59 - Insider Monkey

May 31, 2025
pulisher
May 30, 2025

Bio-Techne stock price target cut to $65 by Argus - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Wells Fargo Initiates Coverage on Bio-Techne (TECH) with Overwei - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Wells Fargo starts Bio-Techne with Overweight, $59 target By Investing.com - Investing.com Canada

May 30, 2025
pulisher
May 30, 2025

Demystifying Bio-Techne: Insights From 7 Analyst Reviews - Benzinga

May 30, 2025
pulisher
May 30, 2025

Wells Fargo Initiates Coverage on Bio-Techne (TECH) with Overweight Rating | TECH Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Argus Adjusts Price Target on Bio-Techne to $65 From $90 - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Wells Fargo starts Bio-Techne with Overweight, $59 target - Investing.com

May 30, 2025
pulisher
May 30, 2025

Wells Fargo Initiates Bio-Techne at Overweight With $59 Price Target - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Bio-Techne Corporation (TECH): A Bull Case Theory - Insider Monkey

May 30, 2025
pulisher
May 29, 2025

Bio-Techne Corporation: An Insight Into The Pharmaceutical Market Dynamics & China's Economic & Regulatory Environment! - Smartkarma

May 29, 2025
pulisher
May 29, 2025

Is Bio-Techne Stock The Right Pick For Your Portfolio Now? - Barchart.com

May 29, 2025
pulisher
May 29, 2025

Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Bio-Techne Sets Triple Conference Appearance: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Bio-Techne to Present at Investor Conferences - Yahoo Finance

May 29, 2025
pulisher
May 22, 2025

Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN

May 22, 2025
pulisher
May 22, 2025

Cetera Investment Advisers Sells 887 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World

May 22, 2025
pulisher
May 21, 2025

Do Wall Street Analysts Like Bio-Techne Stock? - MSN

May 21, 2025
pulisher
May 20, 2025

(TECH) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 20, 2025
pulisher
May 16, 2025

Bio-Techne (NASDAQ:TECH) Rating Increased to Buy at StockNews.com - Defense World

May 16, 2025
pulisher
May 15, 2025

Ex-Dividend Reminder: Bio-Techne, First Hawaiian and Affiliated Managers Group - Nasdaq

May 15, 2025
pulisher
May 14, 2025

Wednesday Sector Laggards: Healthcare, Materials - Nasdaq

May 14, 2025
pulisher
May 14, 2025

What Makes Bio-Techne Corporation (TECH) a Compelling Addition? - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) - Quantisnow

May 14, 2025
pulisher
May 13, 2025

Bio-Techne at BofA Securities 2025: Strategic Growth Amid Challenges By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Bio-Techne at BofA Securities 2025: Strategic Growth Amid Challenges - Investing.com

May 13, 2025
pulisher
May 13, 2025

Transcript : Bio-Techne Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 10 - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 - The Malaysian Reserve

May 12, 2025
pulisher
May 12, 2025

Bio-Techne to Showcase Next-Generation Solutions for Gene and Ce - GuruFocus

May 12, 2025
pulisher
May 12, 2025

UBS Group Cuts Bio-Techne (NASDAQ:TECH) Price Target to $70.00 - Defense World

May 12, 2025
pulisher
May 10, 2025

When the Price of (TECH) Talks, People Listen - news.stocktradersdaily.com

May 10, 2025
pulisher
May 10, 2025

StockNews.com Downgrades Bio-Techne (NASDAQ:TECH) to Hold - Defense World

May 10, 2025
pulisher
May 09, 2025

Bio-Techne (TECH) Target Price Lowered to $70 by UBS Analyst | T - GuruFocus

May 09, 2025
pulisher
May 09, 2025

UBS Adjusts Price Target on Bio-Techne to $70 From $95, Maintains Buy Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance - MSN

May 09, 2025
pulisher
May 09, 2025

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Bio-Techne, Kytopen collaborate on integrated cellular engineering workflow - TipRanks

May 08, 2025
pulisher
May 08, 2025

Bio-Techne (TECH) Target Price Lowered by RBC Capital | TECH Sto - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne (TECH) Target Price Lowered by RBC Capital | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Benchmark Adjusts Bio-Techne Price Target to $75 From $95 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Bio-Techne (TECH): Benchmark Analyst Lowers Target Price but Maintains Buy Rating | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

BIO-TECHNE (TECH): Analyst Maintains Hold Rating, Lowers Price Target | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference - StreetInsider

May 08, 2025
pulisher
May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Eng - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing | TECH Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Bio-Techne price target lowered to $63 from $72 at RBC Capital - TipRanks

May 08, 2025
pulisher
May 08, 2025

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing - Stock Titan

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Corporation (NASDAQ:TECH) Q3 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Bio-Techne Third Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st

May 08, 2025
pulisher
May 08, 2025

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference | TECH Stock News - GuruFocus

May 08, 2025

Bio Techne Corp Azioni (TECH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
Capitalizzazione:     |  Volume (24 ore):